
1. prenat diagn. 2019 may;39(6):420-430. doi: 10.1002/pd.5446. epub 2019 apr 1.

zika virus pregnancy: maternal exposure congenital zika virus
syndrome.

pomar l(1), musso d(2)(3), malinger g(4), vouga m(1), panchaud a(5), baud d(1).

author information: 
(1)department "woman-mother-child", lausanne university hospital, materno-fetal
and obstetrics research unit, lausanne, switzerland.
(2)aix marseille university, ird, ap-hm, ssa, vitrome, ihu-méditerranée
infection, marseille, france.
(3)private practitioner, punaauia, tahiti, french polynesia.
(4)division ultrasound obstetrics & gynecology, lis maternity hospital, tel
aviv sourasky medical center & sackler faculty medicine, tel aviv university, 
tel aviv, israel.
(5)school pharmaceutical sciences, geneva university service pharmacy, 
lausanne university hospital, lausanne, switzerland.

publisher: zika virus (zikv), vector-borne virus similar dengue virus, was
responsible global epidemic 2013 2017 emerged new 
agent responsible severe fetopathies. present review describe the
risks complications maternal subsequent fetal infection zikv. the
risk zikv infection pregnancy depends incidence disease, 
which highly variable different affected geographic areas (less 1% 
75%). among infected pregnant women, risk adverse fetal/neonatal
outcome estimated 5% 42%, 1% 4% fetal loss 4% 9% of
suspected congenital zika syndrome (czs). estimated rate maternal-fetal
transmission ranges 7% 26%, depending methodology the
study. findings associated czs microcephaly (33%-64%), ventriculomegaly 
(63%-92%), calcifications (71%-92%), malformations cortical development
(79%-82%), anomalies corpus callosum (71%-100%) posterior fossa
(21%-82%), arthrogryposis (10%-25%), eye abnormalities (25%), and
extra-neurologic signs intra uterine growth restriction (14%),
placentomegaly, transient hepatitis, mild anemia. infants present czs at
birth suffer motor abnormalities (77%-100%), epilepsy (9%-54%), hearing
loss, neurologic impairments. prenatal ultrasound advanced
neurosonography appropriate virological follow-up represent state-of-the 
art approach adequately monitor at-risk pregnancies, order diagnose
early signs czs inform parents neonatal prognosis.
doi: 10.1002/pd.5446 
pmid: 30866073  [indexed medline]

